Advertisement
Screener

GENTEX CORPORATION (GNTX) Equity Method Investment, Other than Temporary Impairment

2.0 / 5 stars · 44/111 Roast Me

GENTEX CORPORATION Equity Method Investment, Other than Temporary Impairment

GENTEX CORPORATION (GNTX) reported Equity Method Investment, Other than Temporary Impairment of $12.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-08-04

  • GENTEX CORPORATION equity method investment, other than temporary impairment for the quarter ending 2026-06-30 was $9.42M, a 52.44% increase year-over-year.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for the quarter ending 2026-03-31 was $2.74M.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for the quarter ending 2025-12-31 was $5.71M.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for the quarter ending 2025-09-30 was $2.20M.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for fiscal 2025 was $14.08M.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for fiscal 2024 was $0.00.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for fiscal 2023 was $0.00.
  • GENTEX CORPORATION equity method investment, other than temporary impairment for fiscal 2009 was $1.29M.
Period endEquity Method Investment, Other than Temporary Impairment 3 monthEquity Method Investment, Other than Temporary Impairment 6 monthEquity Method Investment, Other than Temporary Impairment 9 monthEquity Method Investment, Other than Temporary Impairment 12 month
2026-06-30$9.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$12.16M
10-Q · filed 2026-08-04
$17.87M
derived: sum of 3 quarters · filed 2026-08-04
$20.07M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$2.74M
10-Q · filed 2026-05-06
$8.45M
derived: sum of 2 quarters · filed 2026-05-06
$10.65M
derived: sum of 3 quarters · filed 2026-05-06
$16.83M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$5.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$7.91M
derived: sum of 2 quarters · filed 2026-02-24
$14.09M
derived: sum of 3 quarters · filed 2026-08-04
$14.08M
10-K · filed 2026-02-24
2025-09-30$2.20M
10-Q · filed 2025-11-07
$8.38M
derived: sum of 2 quarters · filed 2026-08-04
$8.38M
10-Q · filed 2025-11-07
$8.38M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$6.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$6.18M
10-Q · filed 2026-08-04
$6.18M
derived: sum of 3 quarters · filed 2026-08-04
$6.18M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$0.00
10-Q · filed 2026-05-06
$0.00
derived: sum of 2 quarters · filed 2026-05-06
$0.00
derived: sum of 3 quarters · filed 2026-05-06
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$0.00
derived: sum of 2 quarters · filed 2026-02-24
$0.00
10-K · filed 2026-02-24
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
2024-06-30$0.00
10-Q · filed 2025-08-08
2023-12-31$0.00
10-K · filed 2026-02-24
2009-12-31$1.29M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Garrett Motion Inc. (GTX)$4.732B9.95
Atmus Filtration Technologies Inc. (ATMU)United States$3.656B19.39
Dorman Products, Inc. (DORM)United States$3.641B18.26
LEAR CORP (LEA)United States$5.831B11.79
Versigent PLC (VGNT)$3.205B
DANA Inc (DAN)United States$2.944B2.63
VISTEON CORP (VC)United States$2.398B16.55
PHINIA INC. (PHIN)United States$2.197B22.60
PATRICK INDUSTRIES INC (PATK)United States$2.176B20.75
LCI INDUSTRIES (LCII)United States$2.034B12.21